REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)
CUSIP: 76152G100
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 12,805,677
- Total 13F shares
- 865,615
- Share change
- -944,854
- Total reported value
- $1,376,000
- Put/Call ratio
- 42%
- Price per share
- $1.59
- Number of holders
- 15
- Value change
- -$905,812
- Number of buys
- 10
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 76152G100?
CUSIP 76152G100 identifies RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76152G100:
Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.4%
|
1,200,000
|
$1,320,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
464,808
|
$511,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
80,673
|
$88,000 | — | 30 Jun 2022 | |
| EMC Capital Management |
13F
|
Company |
0.43%
|
55,078
|
$62,000 | — | 30 Jun 2022 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.16%
|
20,000
|
$22,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
18,200
|
$20,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
10,584
|
$12,000 | — | 30 Jun 2022 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.07%
|
9,299
|
$10,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.05%
|
6,905
|
$8,000 | — | 30 Jun 2022 | |
| VEDANTA PARTNERS, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
1,127,207
mixed-class rows
|
— | — | 08 Sep 2022 |
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q3 2022
As of 30 Sep 2022,
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
865,615 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, CITADEL ADVISORS LLC, RAYMOND JAMES & ASSOCIATES, SABBY MANAGEMENT, LLC, SIMPLEX TRADING, LLC, and JANE STREET GROUP, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
9
Q3 2022 holders
15
Holder diff
6
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.